Nagaraju, Ganji Purnachandra <br/><br/>
Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer.  [electronic resource] 

 -  Cancer letters  Dec 2013 
 - 195-203 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2013.08.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Western<br/>Cadherins--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Curcumin--analogs & derivatives<br/>Cytosine--metabolism<br/>DNA (Cytosine-5-)-Methyltransferase 1<br/>DNA (Cytosine-5-)-Methyltransferases--genetics<br/>DNA Methylation--drug effects<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HSP90 Heat-Shock Proteins--genetics<br/>Humans<br/>Immunohistochemistry<br/>Mice<br/>Mice, Nude<br/>Osteonectin--genetics<br/>Pancreatic Neoplasms--drug therapy<br/>Piperidones--pharmacology<br/>Pyridines<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Xenograft Model Antitumor Assays